Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2026-04-21 @ 9:54 AM
Study NCT ID:
NCT06187506
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer
Sponsor:
Organization: